(Q47983735)

7 February 2018

title

Isolation and characterization of Saccharomyces cerevisiae mutants with enhanced resistance to the anticancer drug bleomycin. (English)

1 reference

7 February 2018

main subject

Saccharomyces cerevisiae

1 reference

Mustapha Aouida

1

1 reference

7 February 2018

Omar Tounekti

2

1 reference

7 February 2018

Anick Leduc

3

1 reference

7 February 2018

Omrane Belhadj

4

1 reference

7 February 2018

Lluis Mir

5

1 reference

7 February 2018

Dindial Ramotar

6

1 reference

7 February 2018

publication date

9 March 2004

1 reference

7 February 2018

published in

Current Genetics

1 reference

7 February 2018

volume

45

1 reference

7 February 2018

page(s)

265-272

1 reference

7 February 2018

issue

5

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1007/s00294-004-0492-x

exact match

0 references

cites work

Stable [57Co]-bleomycin complex with a very high specific radioactivity for use at very low concentrations

1 reference

12 December 2020

Characterization of two independent amino acid substitutions that disrupt the DNA repair functions of the yeast Apn1.

1 reference

12 December 2020

Getting started with yeast

1 reference

12 December 2020

Genotoxicity of bleomycin

1 reference

12 December 2020

Protective mechanisms against the antitumor agent bleomycin: lessons from Saccharomyces cerevisiae

1 reference

12 December 2020

Bleomycin: new perspectives on the mechanism of action

1 reference

12 December 2020

Natural and artificial bleomycins: chemistry and antitumor activities

1 reference

12 December 2020

Identification of a plasma membrane protein that specifically binds bleomycin

1 reference

12 December 2020

Disruption of the Saccharomyces cerevisiae cell-wall pathway gene SLG1 causes hypersensitivity to the antitumor drug bleomycin

1 reference

12 December 2020

Binding of bleomycin to DNA in bleomycin-sensitive and -resistant rat ascites hepatoma cells

1 reference

12 December 2020

Comparative roles of the cell wall and cell membrane in limiting uptake of xenobiotic molecules by Saccharomyces cerevisiae

1 reference

12 December 2020

IMP2, a gene involved in the expression of glucose-repressible genes in Saccharomyces cerevisiae

1 reference

12 December 2020

Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals

1 reference

12 December 2020

Neutralization of bleomycin hydrolase by an epitope-specific antibody

1 reference

12 December 2020

Three new dominant drug resistance cassettes for gene disruption in Saccharomyces cerevisiae

1 reference

12 December 2020

Induced mutagenesis by bleomycin in the purple sulfur bacterium Thiocapsa roseopersicina

1 reference

12 December 2020

Curing metastatic testicular cancer

1 reference

12 December 2020

Metabolic inactivation: a mechanism of human tumor resistance to bleomycin.

1 reference

12 December 2020

Internalisation of the bleomycin molecules responsible for bleomycin toxicity: a receptor-mediated endocytosis mechanism

1 reference

12 December 2020

The transcriptional activator Imp2p maintains ion homeostasis in Saccharomyces cerevisiae

1 reference

12 December 2020

Involvement of membrane bleomycin-binding sites in bleomycin cytotoxicity

1 reference

12 December 2020

In vivo circumvention of human colon carcinoma resistance to bleomycin

1 reference

12 December 2020

Bleomycin-resistant cells contain increased bleomycin-hydrolase activities

1 reference

12 December 2020

1 reference

12 December 2020

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

12 December 2020

Deletions at short direct repeats and base substitutions are characteristic mutations for bleomycin-induced double- and single-strand breaks, respectively, in a human shuttle vector system

1 reference

12 December 2020

Effect of in vitro cleavage of apurinic/apyrimidinic sites on bleomycin-induced mutagenesis of repackaged lambda phage

1 reference

12 December 2020

Establishment of human squamous carcinoma cell lines highly and minimally sensitive to bleomycin and analysis of factors involved in the sensitivity

1 reference

12 December 2020

Frequencies of HPRT mutants and micronuclei in lymphocytes of cancer patients under chemotherapy: a prospective study

1 reference

12 December 2020

Response of a murine solid tumor to in vivo combined chemotherapy and irradiation.

1 reference

12 December 2020

Bleomycin: revival of an old drug

1 reference

12 December 2020

Bleomycin resistance in mammalian cells expressing a genetic suppressor element derived from the SRPK1 gene.

1 reference

12 December 2020

The Saccharomyces cerevisiae IMP2 gene encodes a transcriptional activator that mediates protection against DNA damage caused by bleomycin and other oxidants

1 reference

12 December 2020

Spontaneous cleavage of bleomycin-induced abasic sites in chromatin and their mutagenicity in mammalian shuttle vectors

1 reference

12 December 2020

10.1007/S00294-004-0492-X

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

15007625

1 reference

7 February 2018